Live feed
Filing
SC 13G/A
SC 13G/A0001104659-20-011065·Dexcel Pharma Technologies Ltd.
Schedule 13G ownership disclosure
Intec Pharma Ltd.
Security class unavailable · CUSIP: M53644106
Event date: 2020-02-04
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 4,234,897
- Percent of class
- 8.1000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001104659-20-011065
- Form type
- SC 13G/A
- Filer
- Dexcel Pharma Technologies Ltd.
- CIK
- CIK 1720007
- Filed
- Feb 05, 2020
- Reporting period
- Feb 04, 2020
- Description
- Schedule 13G beneficial ownership